دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Evidence-based Reviews: Systematic Reviews and Meta-analyses
Twa, Michael D. OD, PhD, FAAO
doi : 10.1097/OPX.0000000000001848
Number: Volume 99(1), January 2022, p 1-2
Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Vision Rehabilitation Utilization
Winkler, Sandra L. PhD, OTR/LÂ 1*Â ;Â Marszalek, Jacob PhDÂ 2Â ;Â Wang, Xinping PhDÂ 3Â ;Â Finch, Dezon PhDÂ 1Â ;Â Rakoczy, Chrystyna OD, FAAOÂ 1Â ;Â Delikat, Jemy MOTÂ 1Â ;Â Kelleher, Valerie AAÂ 1Â ;Â Williams, Michael PhDÂ 4Â ;Â Zuniga, Esteban MAÂ 4Â ;Â Rice, Candice OD, FAAOÂ 5Â ;Â Pollard, Kendra OD, FAAOÂ 6Â ;Â Cockerham, Glenn MDÂ 7.8
doi : 10.1097/OPX.0000000000001824
Number: Volume 99(1), January 2022, p 3-8
Visual dysfunction is frequently associated with traumatic brain injury (TBI). Although evidence regarding the prevalence of symptoms of this population has been published, little is known about health care utilization. A retrospective review of the data derived from the Department of Veterans Affairs (VA)-mandated "Traumatic Brain Injury Specific Ocular Health and Visual Functioning Examination for Polytrauma Rehabilitation Center Patients" provided a unique opportunity to investigate vision rehabilitation utilization.
Veterans with Traumatic Brain Injury-related Ocular Injury and Vision Dysfunction: Recommendations for Rehabilitation
Winkler, Sandra L. PhD, OTR/L 1* ; Finch, Dezon PhD 1 ; Wang, Xinping PhD 2 ; Toyinbo, Peter PhD 1 ; Marszalek, Jacob PhD 3 ; Rakoczy, Chrystyna M. OD 1 ; Rice, Candice E. OD 4 ; Pollard, Kendra OD 5 ; Rhodes, Matthew A. OD 6 ; Eldred, Kia OD7 ; Llanos, Imelda OTR/L 1 ; Peterson, Michael OD 8 ; Williams, Michael PhD 9 ; Zuniga, Esteban MA 9 ; White, Helen MBA10 ; Delikat, Jemy MOT 1 ; Ballistrea, Lisa DPT 1 ; White, Keith MD1 ; Cockerham, Glenn C MD 11.12
doi : 10.1097/OPX.0000000000001828
Number: Volume 99(1), January 2022, p 9-17
We know the prevalence of traumatic brain injury (TBI)-related vision impairment and ocular injury symptoms. Lacking is an understanding of health care utilization to treat these symptoms. Utilization knowledge is important to structuring access to treatment, identifying clinical training needs, and providing evidence of the effectiveness of treatment.
Feasibility of Implementing Recommendations to Reduce Fall Risk in Older People: A Delphi Study
Ho, Kam Chun PhD, FAAO 1,2,3 ; Elliott, David PhD, FAAO 4 ; Charlesworth, Emily MC Optom 4 ; Gyawali, Rajendra MOptom, FAAO 1 ; Keay, Lisa PhD 1.2*
doi : 10.1097/OPX.0000000000001829
Number: Volume 99(1), January 2022, p 18-23
This study provides guidance for the implementation of recommendations for falls prevention in optometry practice, through synthesis with the optometrists' viewpoint as a major stakeholder. Educators and clinicians can adopt the revised recommendations and associated implementation strategies in this research for successful integration into optometric practice.
Development of Visual Acuity in Children: Assessing the Contributions of Cognition and Age in LEA Chart Acuity Readings
Myklebust, Arnulf K. PhD, MScOptom 1* ; Riddell, Patricia M. DPhil, MSc 2
doi : 10.1097/OPX.0000000000001822
Number: Volume 99(1), January 2022, p 24-30
The development of visual acuity has often been looked upon as a function of age. This study considers whether cognition might also be a predictor of acuity in children. The results indicate that cognition is a predictor of acuity and therefore should play a role in vision evaluations and developmental research.
Opioid Prescribing Patterns of Optometrists in the Medicare Part D Database
Dryden, Stephen C. MDÂ 1*Â ;Â O'Malley, Holly A. ODÂ 2Â ;Â Adams, Lindsey R. ODÂ 1Â ;Â Nix, Garrett C. MDÂ 1Â ;Â Rho, Jonathan E. MDÂ 1Â ;Â Vacheron, Albert B. MDÂ 1Â ;Â Fleming, James C. MDÂ 1Â ;Â Fowler, Brian T. MDÂ 1
doi : 10.1097/OPX.0000000000001827
Number: Volume 99(1), January 2022, p 31-34
This study aimed to determine the prescription rates and prescribing trends of opioids by optometrists in the Centers for Medicare & Medicaid Services (CMS) part D database from 2013 to 2017 and to assess opioid prescribing patterns of US optometrists in the CMS part D database
The Scope of Optometry Practice in Jordan
Okasheh-Otoom, Areej PhD 1* ; Gammoh, Yazan PhD 2 ; Otoum, Mohammed BSc 3 ; Naqaweh, Abdullah BSc 1
doi : 10.1097/OPX.0000000000001823
Number: Volume 99(1), January 2022, p 35-44
The scope of optometry practice varies worldwide. Although the scope of optometry practice in Jordan is regulated, discrepancies exist in the services that optometry professionals provide.
Stereothresholds during Voluntary Head Movement and Disconjugate Image Motion
Bedell, Harold E. PhD, FAAOÂ 1*Â ;Â Tsang, Dorcas K. OD, FAAOÂ 2Â ;Â Ukwade, Michael T. OD, PhD, FAAOÂ 1.3
doi : 10.1097/OPX.0000000000001831
Number: Volume 99(1), January 2022, p 45-50
Stereothresholds increase in the presence of disconjugate image motion, whether this motion results from vergence errors that occur during active head movements or is imposed externally.
Effect of Vergence Facility Testing on Horizontal Fusional Reserves
Askarizadeh, Farshad PhD 1 ; Heirani, Mohsen PhD 2 ; Khorrami-Nejad, Masoud PhD 2 ; Khabazkhoob, Mehdi PhD 3,4 ; Narooie-Noori, Foroozan MSc 5*
doi : 10.1097/OPX.0000000000001825
Issue: Volume 99(1), January 2022, p 51-57
The effect of vergence adaptation on test sequences should be considered in clinical practice.
Visual Acuity Outcomes in a Randomized Trial of Wavefront Metric-optimized Refractions in Adults with Down Syndrome.
Anderson, Heather A. OD, PhD, FAAOÂ 1*Â ;Â Marsack, Jason D. PhD, FAAOÂ 2Â ;Â Benoit, Julia S. PhDÂ 2,3Â ;Â Manny, Ruth E. OD, PhD, FAAOÂ 2Â ;Â Fern, Karen D. OD, FAAOÂ 2
doi : 10.1097/OPX.0000000000001834
Number: Volume 99(1), January 2022, p 58-66
This study reports visual acuity outcomes from a clinical trial investigating an objective refraction strategy that may provide a useful tool for practitioners needing additional strategies to identify refractive corrections for adults with intellectual disability.
Effect of a Novel Omega-3 and Omega-6 Fatty Acid Supplement on Dry Eye Disease: A 3-month Randomized Controlled Trial
Ng, Alison PhD, FAAOÂ 1*Â ;Â Woods, Jill MSc, FAAOÂ 1Â ;Â Jahn, Theresa ND, MBAÂ 2Â ;Â Jones, Lyndon W. PhD, DSc, FAAOÂ 1,3Â ;Â Sullivan Ritter, Jenna PhDÂ 2
doi : 10.1097/OPX.0000000000001826
Number: Volume 99(1), January 2022, p 67-75
Supplementing diet with a novel combination of omega-3 and omega-6 fatty acids significantly improved symptoms in extremely symptomatic participants with dry eye disease (DED).
Case Report: Swept-source Optical Coherence Tomography and Angiography Findings in Lipemia Retinalis
Bouraoui, Rim MDÂ 1,2,3Â ;Â El Matri, Khaled MDÂ 1,2,3*Â ;Â Derouiche, Kaouther MDÂ 3.4Â ;Â Falfoul, Yousra MDÂ 1,2,3Â ;Â Amrouche, Chiraz MDÂ 3.4Â ;Â Hachicha, Ines MDÂ 1.3Â ;Â Othmani, Emna MDÂ 2.3Â ;Â Mghaieth, Fatma MDÂ 1,2,3Â ;Â El Matri, Leila MDÂ 1,2,3
doi : 10.1097/OPX.0000000000001830
Number: Volume 99(1), January 2022, p 76-81
Lipemia retinalis is a very rare ocular manifestation of severe hypertriglyceridemia. It is usually symptomatic and regresses after normalization of triglycerides levels. Early recognition is important to prevent ocular and life-threatening complications.
Case Report: Longitudinal Effect of Progressive Epiretinal Membrane on the Retinal Nerve Fiber Layer
LePosa, Adam C. OD, FAAO 1* ; Cason, Daniel OD, MBA1 ; Arteaga, Rigoberto OD 1
doi : 10.1097/OPX.0000000000001832
Issue: Volume 99(1), January 2022, p 82-87
Epiretinal membrane is a common macular pathology known to cause morphologic changes observed on macular optical coherence tomography (OCT) and retinal nerve fiber layer (RNFL) OCT. However, the longitudinal effect of epiretinal membrane progression on RNFL OCT morphology is not well studied.
Case Report: Erdafitinib-induced Central Serous Chorioretinopathy
Claiborne, Richard T. OD, FAAOÂ 1*Â ;Â Tsan, Grace L. OD, FAAOÂ 2.3
doi : 10.1097/OPX.0000000000001833
Number: Volume 99(1), January 2022, p 88-92
Erdafitinib is the first fibroblast growth factor receptor inhibitor approved by the US Food and Drug Administration in April 2019 for the treatment of locally advanced and unresectable or metastatic urothelial carcinoma. Central serous chorioretinopathy is a common ocular adverse effect requiring frequent monitoring with ophthalmic examination.
